Investigative Urology - Results from #6080

The hinge region in androgen receptor control - Abstract May 17, 2012

Regulation of thrombomodulin expression in prostate cancer cells - Abstract May 17, 2012

IQGAP2, A candidate tumour suppressor of prostate tumorigenesis - Abstract May 17, 2012

microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor - Abstract May 17, 2012

Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression - Abstract May 17, 2012

The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activity - Abstract May 16, 2012

Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer - Abstract May 16, 2012

An artificially constructed radiation-responsive promoter is activated by doxorubicin - Abstract May 16, 2012

Androgen action in the prostate gland - Abstract May 16, 2012

Prostate cancer stem cell biology - Abstract May 16, 2012

Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis - Abstract May 16, 2012

Developing a nanoparticle test for prostate cancer scoring - Abstract May 16, 2012

Inverse relationship between PSA and IL-8 in prostate cancer: an insight into a NF-κB-mediated mechanism - Abstract May 16, 2012

The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells - Abstract May 15, 2012

The androgen/androgen receptor axis in prostate cancer - Abstract May 15, 2012

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial - Abstract May 15, 2012

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial - Abstract May 15, 2012

Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells - Abstract May 15, 2012

IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility - Abstract May 15, 2012

Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts - Abstract May 14, 2012

Page 305 of 346